SG11202105686UA - Therapeutic agent of peripheral blood flow disorder - Google Patents

Therapeutic agent of peripheral blood flow disorder

Info

Publication number
SG11202105686UA
SG11202105686UA SG11202105686UA SG11202105686UA SG11202105686UA SG 11202105686U A SG11202105686U A SG 11202105686UA SG 11202105686U A SG11202105686U A SG 11202105686UA SG 11202105686U A SG11202105686U A SG 11202105686UA SG 11202105686U A SG11202105686U A SG 11202105686UA
Authority
SG
Singapore
Prior art keywords
therapeutic agent
blood flow
peripheral blood
flow disorder
disorder
Prior art date
Application number
SG11202105686UA
Other languages
English (en)
Inventor
Satoaki Matoba
Mari Dezawa
Original Assignee
Kyoto Prefectural Public Univ Corp
Life Science Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto Prefectural Public Univ Corp, Life Science Institute Inc filed Critical Kyoto Prefectural Public Univ Corp
Publication of SG11202105686UA publication Critical patent/SG11202105686UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/54Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11202105686UA 2018-11-30 2019-11-29 Therapeutic agent of peripheral blood flow disorder SG11202105686UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018225295 2018-11-30
PCT/JP2019/046847 WO2020111249A1 (ja) 2018-11-30 2019-11-29 末梢血流障害の治療剤

Publications (1)

Publication Number Publication Date
SG11202105686UA true SG11202105686UA (en) 2021-06-29

Family

ID=70853028

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202105686UA SG11202105686UA (en) 2018-11-30 2019-11-29 Therapeutic agent of peripheral blood flow disorder

Country Status (8)

Country Link
US (1) US20220000936A1 (enExample)
EP (1) EP3888751B1 (enExample)
JP (1) JP7473207B2 (enExample)
CN (1) CN113195054A (enExample)
AU (1) AU2019388016B2 (enExample)
CA (1) CA3121444A1 (enExample)
SG (1) SG11202105686UA (enExample)
WO (1) WO2020111249A1 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9550975B2 (en) 2009-07-15 2017-01-24 Mari Dezawa SSEA-3 pluripotent stem cell isolated from body tissue
WO2012024296A1 (en) * 2010-08-20 2012-02-23 University Of Miami Arterial repair with cultured bone marrow cells and whole bone marrow
CN102641297B (zh) * 2011-02-21 2016-02-24 杨子江 治疗外周动脉粥样硬化引起的缺血性疾病的制剂及其制备方法
JP7029729B2 (ja) * 2016-07-29 2022-03-04 国立大学法人東北大学 血管障害の予防又は治療剤

Also Published As

Publication number Publication date
KR20210099014A (ko) 2021-08-11
JP7473207B2 (ja) 2024-04-23
AU2019388016B2 (en) 2024-12-19
EP3888751A1 (en) 2021-10-06
EP3888751B1 (en) 2024-04-17
AU2019388016A1 (en) 2021-07-08
WO2020111249A1 (ja) 2020-06-04
EP3888751C0 (en) 2024-04-17
CA3121444A1 (en) 2020-06-04
CN113195054A (zh) 2021-07-30
US20220000936A1 (en) 2022-01-06
JPWO2020111249A1 (enExample) 2020-06-04
EP3888751A4 (en) 2022-10-05

Similar Documents

Publication Publication Date Title
IL280707B1 (en) Diagnostic and therapeutic methods for treating breast cancer
PL3600309T3 (pl) Skojarzenia terapeutyczne do leczenia chorób wątroby
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
EP3709882A4 (en) DIAGNOSTIC AND THERAPEUTIC SPLINTS
PT3122878T (pt) Terapia de arnm para o tratamento de doenças oculares
IL258854A (en) Preparations containing cannabidiol and secondary medicinal agents for cancer treatment
IL292810A (en) Therapeutic compounds and methods of use
EP3253451A4 (en) Diagnosis and treatment of chronic pain
HUE060496T2 (hu) Terápiás vegyületek és készítmények szociális zavarok és szerhasználati zavarok kezelésére
IL269083A (en) Methods for preventing and treating heart disease
IL272097A (en) Compounds for the prevention and treatment of medical disorders and their uses
GB201805100D0 (en) Treatment of sarcopenic diseases
GB201813312D0 (en) Compounds and their therapeutic use
PT3458045T (pt) Ebselen para uso no tratamento da doença de ménière
GB202015959D0 (en) Treatment of diseases involving NAD
IL291372A (en) Treatment of chronic granulomatous disease
GB201717625D0 (en) Device for treatment of chronic respiratory diseases
ES3049333T3 (en) Compounds for the treatment of respiratory diseases
EP3349797A4 (en) LOCALIZED RELEASE OF ANTIFUGETACTIC AGENT FOR THE TREATMENT OF CANCER
IL274132A (en) Treatment of skin problems
SG11202105686UA (en) Therapeutic agent of peripheral blood flow disorder
GB201412842D0 (en) Catheter for the delivery of therapeutic fluid
GB201820994D0 (en) Methods of treatment and diagnosis of tumours
PL3431119T3 (pl) Aparat do pozaustrojowego oczyszczania krwi
EP4031667C0 (en) CA-IX APTAMERS AND THEIR DIAGNOSTIC AND THERAPEUTIC USES